SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001457612-18-000090
Filing Date
2018-09-24
Accepted
2018-09-24 16:12:22
Documents
11
Period of Report
2018-09-24
Items
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gnca8k92418.htm 8-K 24807
2 EXHIBIT 14.1 finalcodeofbusinessethic.htm EX-14.1 25186
3 finalcodeofbusinessethic001.jpg GRAPHIC 205077
4 finalcodeofbusinessethic002.jpg GRAPHIC 202749
5 finalcodeofbusinessethic003.jpg GRAPHIC 224541
6 finalcodeofbusinessethic004.jpg GRAPHIC 224141
7 finalcodeofbusinessethic005.jpg GRAPHIC 189183
8 finalcodeofbusinessethic006.jpg GRAPHIC 148705
9 finalcodeofbusinessethic007.jpg GRAPHIC 200389
10 finalcodeofbusinessethic008.jpg GRAPHIC 111995
11 finalcodeofbusinessethic009.jpg GRAPHIC 67883
  Complete submission text file 0001457612-18-000090.txt   2221157
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 181083559
SIC: 2836 Biological Products, (No Diagnostic Substances)